Scrapping pre-approval of medicine ads will put consumers at risk

Ken Harvey, Bruce Baer Arnold

Research output: Contribution to Newspaper/Magazine/BulletinArticle

1 Downloads (Pure)

Abstract

A government bill, currently before a Senate inquiry, aims to simplify the process for advertising medicines. These include over-the-counter products such as Nurofen, and complementary medicines such as vitamins, herbals and homeopathic products. Advertising for prescription medication is not permitted in Australia.

If the bill passes, the current limited (but useful) process of pre-approving claims made in advertisements for medicines, to ensure they don’t mislead or deceive consumers, will be abandoned. This means advertisements are seen by two industry bodies before they are published or aired. Where problems are found, the bodies work with the advertiser to ensure compliance
Original languageEnglish
Pages1-4
Number of pages4
Volume2018
No.Jan
Specialist publicationThe Conversation
PublisherThe Conversation Paperpress
Publication statusPublished - 25 Jan 2018

Fingerprint

Dive into the research topics of 'Scrapping pre-approval of medicine ads will put consumers at risk'. Together they form a unique fingerprint.

Cite this